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FIGURE 1: Metabolic pathways in C. acetobutylicum 
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iunino acid sequence ofFe1redoxin--NADP reductase (FNR) ofChlarobium tepidurn TLS 
(Genebank ~-\ccession Q8KCB2) 
1 mldihnpatd hhdmrdltii gggptgifaa fgcgmnnisc riiesmpqlg gglaalypek 
61 hiydvagfpe vpaidlvesl 1,-,aqaerynpd vYlnetvtky tklddgtfet rtntgnvyrs 
121 ravliaaglg afeprklpql gnidhl tgss vyyavksved fkgkrvvivg ggdsaldwtv· 
181 gliknaasvt lvhrghefqg hgktahever arangtidvy letevasiee sngvltrvhl 
241 rssdgskwtv eadrllilig fksnlgplar wdlelyenal vvdshmktsv dglyaagdia 
301 yypgklkiiq tglseatrnav rhslsyikpg ekirnvfssv kmakekkaae agnatenkae 
FIGURE 2A: SEQ ID N0.1 
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Codon optimized nucleotide sequence of FN"R gene for expression in Cl. acetobutylic1 
(1080 b ) 
. p 
ATGTTAGATA 
TCCATAATCC AGCAACCGAC CACCATGATA TGAGAGATTT GACTATTATC GGCGGTGGTC 
CGACCGGGAT ATTTGCTGCC TTTCAATGTG GTATGAATJI..A CATATCATGC AGAATCATTG 
A.r...TCTATGCC TCAA.TTGGGT GGTCAACTTG CTGCACTATA TCCAGAAAAA CATATCTATG 
ACGTTGCAGG ATTTCCCGP..A GTTCCAGCTA TTGATTTGGT TGAGTCATTA TGGGCACAAG 
CGGAAAGATA TAACCCAGA.T GTCGTCCTTA ATGA..:i;ACAGT P...ACCAAGTAT ACCAAATTAG 
ACGATGGGAC GTTTGAGACT AGAACCJtATA CAGGTP..ATGT TTATCGATCA AGAGCTGTAC 
TTATTGCAGC GGGATTAGGA GCATTTGAAC CACGTF-.AACT TCCCCAATTA GGCAATJ. .. TAG 
ATCATCTA..Z:....C CGGTAGTTCT GTATACTATG CGGTTF-.AAAG CGTTGAAGAT TTCAAAGGTA 
AAAGAGTTGT TATAGTCGGT GGTGGAGACA GCGCCTTAGA CTGGACCGTC GGACTTATCA 
AAAATGCTGC P..TCAGTAACA TTAGTGCACA GAGGACATGA ATTTCAAGGT CATGGTAP.AA 
CCGCCCATGA P..GTGGAP.AGA GCP..AGAGCTA ATGGTACTAT TGATGTGTAT TTGGJ...AACAG 
AGGTAGCAAG CATTGAAGAG TCTAATGGAG TATTAACTAG AGTTCATCTT AGATCAAGTG 
ACGGTTCAAA GTGGACTGTT GAAGCGGATA GACTTCTTAT TCTAATAGGT TTTAAGTCAA 
ACTTAGGTCC TTTAGCAAGA TGGGATTTAG AACTTTATGA AAATGCTTTA GTTGTTGATT 
CTCACATGAA AACTTCCGTT GACGGACTTT ATGCTGCAGG AGACATTGCA TATTACCCGG 
GGAAATTGAA AATCATACAG ACTGGGTTA.T CAGAAGCGAC TATGGCTGTA AGGCATTCCC 
TTAGTTATAT CAA..~CCTGGT GAGAAAATAC GTAACGTGTT CAGTTCCGTC A..~GATGGCGA 
A..r...GAAAAGAA AGCCGCAGJ:..A GCTGGGAATG CTACTGAGJ:..A TAAGGCTGAG 
FIGURE 28: SEQ ID NO. 2 
Rbs: AGGAGGT AAAACAT 
FIGURE 2C: SEQ ID NO. 3. 
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MAKING C4+ PRODUCTS IN BACTERIA 
PRIOR RELATED APPLICATIONS 
This Application claims priority to 62/016,842, filed Jun. 
25, 2014, and incorporated by reference herein in its entirety 
for all purposes. 
FEDERALLY SPONSORED RESEARCH 
STATEMENT 
This invention was made with govermnent support under 
CBET-1033552 awarded by the NSF. The government has 
certain rights in the invention. 
FIELD OF THE DISCLOSURE 
The disclosure generally relates to biological methods of 
making hydrocarbon feedstocks, in particular longer chain 
length organic acids and alcohols made in anaerobic 
microbes. 
BACKGROUND OF THE DISCLOSURE 
Four to ten carbon alkanes have many uses in our society, 
particularly as fuels and as feedstock for more complex 
chemicals. Most, however, are produced from petroleum, a 
dwindling reserve whose use creates significant ecological 
impact. 
Butane (C4), for example, is mainly used for gasoline 
blending, as a fuel gas, either alone or in a mixture with 
propane, and as a feedstock for the manufacture of ethylene 
and butadiene, a key ingredient of synthetic rubber. Isobu-
tane is primarily used by refineries to enhance the octane 
content of motor gasoline. 
Very pure forms of butane, especially isobutane, can be 
used as refrigerants and have largely replaced the ozone 
layer-depleting halomethanes, for instance in household 
refrigerators and freezers. The system operating pressure for 
butane is lower than for the halomethanes, such as R-12, so 
R-12 systems such as in automotive air conditioning sys-
tems, when converted to butane will not function optimally. 
Butane is also used as lighter fuel for a common lighter or 
butane torch and is sold bottled as a fuel for cooking and 
camping, and cordless hair irons are usually powered by 
butane cartridges. 
In industry, hexanes (C6) are used in the formulation of 
glues for shoes, leather products, and roofing. They are also 
used to extract cooking oils from seeds, for cleansing and 
degreasing a variety of items, and in textile manufacturing. 
2 
Thus, we can see that there are many important uses for 
low carbon number alkanes and the demand for C4+ alkanes 
is not expected to diminish any time soon. Yet as products 
of petroleum refining, the production of such alkanes con-
5 tributes significantly to environmental degradation, and as 
our hydrocarbon resources continue to dwindle in availabil-
ity, the alkanes can only be expected to increase in price over 
the long term. 
There is also need for alcohols and acids of the C-4+ class 
10 such as butyrate, hexanoic acid, etc. and the corresponding 
alcohols that are used in many chemical processes. Chemi-
cal processes are known for interconversions among the 
C-4+ series of carbon compounds and used by the petro-
chemical industry, so a source of a particular reduced C-4+ 
15 compound can be useful for a variety of potential industrial 
processes. 
Thus, what are needed in the art are biological sources for 
these important alkanes, and microbial production is being 
investigated in that regard. Unfortunately, not many bacteria 
20 make butane or hexane, at least not in significant amounts, 
and some of the bacteria that do are obligate anaerobes, 
which are difficult and expensive to culture. 
Professor David Mullin, and his team have discovered a 
new bacteria, called Tu-103, a butane-producing bacteria 
25 that lives on glycerol-a byproduct ofbiodiesel synthesis, or 
on cellulose-a waste product in abundant supply from e.g., 
old newspapers. The microbe is unique because it can do this 
in the presence of oxygen, unlike some other types of 
bacterium, which means less expensive production tech-
30 niques would be required than for most obligate anaerobes. 
However, little is known about this bacteria because details 
are being kept as a trade secret, and future patents may also 
prevent its use. 
Nonetheless, the existence of such organisms has gener-
35 ated renewed interest in solventogenic bacteria, such as 
Clostridia, because it is anticipated that additional strains 
will be discovered that have some degree of tolerance to 
oxygen, removing some of the difficulties in using these 
organisms for the bioproduction of desired chemicals. Alter-
40 natively, increasing exposure to oxygen may induce some 
degree of oxygen tolerance, and/or random mutagenesis 
could result in such changes. 
Clostridium acetobutylicum, for example, is an anaerobic, 
spore-forming prokaryote that produces the solvents buta-
45 no!, acetone, and ethanol. The desired product of the C. 
acetobutylicum fermentation is butanol, which has superior 
fuel characteristics to ethanol, such as higher energy content 
and lower water miscibility. The C. acetobutylicum genome 
has been completely sequenced and annotated, and methods 
50 for genetic deletions and gene overexpression have been 
developed, making it even more attractive organism for 
further strain development. Clostridia can also grow on a 
variety of substrates, from simple pentoses and hexoses to 
A typical laboratory use of hexanes is to extract oil and 
grease contaminants from water and soil for analysis. Since 
hexane cannot be easily deprotonated, it is used in the 
laboratory for reactions that involve very strong bases, such 55 
as the preparation of organolithiums, e.g. butyllithiums are 
typically supplied as a hexane solution. In many applications 
(especially pharmaceutical), the use of n-hexane is being 
phased out due to its long term toxicity, and often replaced 
complex polysaccharides. 
The metabolism of C. acetobutylicum is typically biphasic 
in batch culture-the cells first produce acetate and butyrate, 
and later-butanol, acetone, and ethanol. During growth, the 
production of acids lowers the pH of the culture, which 
combined with butyrate accumulation causes a shift in 
by n-heptane, which will not form the toxic metabolite 
hexane-2,5-dione. 
60 metabolism towards solvent production. 
Octanes (CS) became well known in American popular 
culture in the mid- and late-sixties, when gasoline compa-
nies boasted of "high octane" levels in their gasoline adver-
tisements. Thus, it too is useful in fuels. Decane (ClO) 65 
undergoes combustion reactions in a similar fashion to other 
alkanes. 
As solvents are produced, the acids are typically re-
assimilated and converted into solvents. With initiation of 
solvent formation, the cells commit to their sporulation 
program. In continuous culture or upon consecutive vegeta-
tive transfers, cells may degenerate whereby they become 
asporogenic and lose the capability to produce solvents. In 
this organism, the degeneration process is due to the loss of 
US 9,650,654 B2 
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the pSOLl megaplasmid, which carries the key solvent 
formation genes in the so-called sol locus made up of the sol 
operon (aad-ctfA-ctfB) (coding for the enzymes AAD and 
CoAT) and the adc gene ( coding for the enzyme AADC, 
FIG. 5). The use of pSOLl mutants can be beneficial in 5 
certain instances, reducing compet1t10n for carbon 
resources, and driving metabolism towards desired products. 
4 
and reducing NAD+ to NADH and thereby captures the 
redox by minimizing H2 production (FIG. 1, reaction in 
box). 
What are needed in the art are additional methods of 
making C4-10 compounds using microbes. A method using 
some of the advantages of solventogenic bacteria, such as 
Clostridia may be of benefit as well. 
SUMMARY OF THE DISCLOSURE 
This results in increase in NADH availability in vivo that 
is then chamieled towards acetyl-CoA condensation and 
reduction to favor the formation of longer chain organic 
acids (such as butyric acid) and alcohols (such as butanol). 
The functionality of the newly introduced redox capturing 
ferredoxin enzyme was successfully demonstrated in 
10 
anaerobic tube experiments performed in an anaerobic 
chamber. This increase in NADH availability significantly 
changed the final metabolite concentration pattern under 
anaerobic conditions. 
The present invention describes a method to capture redox 
by heterologous expression offerredoxin NAD(P) reductase 
to allow the formation of longer chain organic acids and 
alcohols in anaerobic microbes. 
15 We observed a change in metabolite pattern towards more 
butanol and less acetone in cultures of wild type Clostridia 
ATCC824, and more butyrate and less acetate in cultures of 
ATCC824 and M5 cells expressing FNR. The effect on the 
butyrate to acetate ratio was noticeable in ATCC824 cul-
To demonstrate proof of concept, we used ABE ( acetone: 
butanol:ethanol) producing Clostridium acetobutylicum 
ATCC824, as well as a mutant variant strain M5 that has lost 
the mega plasmid pSOLl (Clark et al. 1989) and a mutant 
variant strain PJC4BK, that is disrupted in buk, the gene 
encoding the major butyrate kinase. 
20 tures. During acidogenic stage (6 hr), the butyrate:acetate 
ratio was -0.7-1.1 in wild type vector control (ATCC824 
(pJIR750)) cultures; whereas, the butyrate:acetate ratio was 
-1.6 for FNR+ (ATCC824(pJIR750-FNR)) cultures (Table 
25 
As noted above, C. acetobutylicum displays two phase 
metabolism tightly associated with different growth stages. 
During the exponential growth, cells mainly produce acetic 
acid, butyric acid, H2 , ATP and NAD(P)H. In response to the 
acidic pH, the metabolism switches to solventogenesis 30 
wherein acids are re-consumed and acetone, butanol and 
ethanol produced to regenerate reducing equivalents. 
A key enzyme of the C. acetobutylicum central metabo-
lism is the pyruvate ferredoxin oxidoreductase (pfor, FIG. 
35 1), which catalyzes the oxidative decarboxylation of pyru-
1 ). 
Significant change was observed in the pattern ofbutanol 
and acetone in the cultures of ATCC824. In wild type 
ATCC824 cells grown to solvent stage, we observed an 
increase in the ratio of butanol:acetone from 1.46 in the 
parental strain with vector, ATCC824(pJIR750), to 2.8 in the 
culture of cells bearing the FNR+ plasmid pJIR750-FNR 
(Table 2). The pattern of acetone and butyrate changed 
significantly in the cultures of ATCC824(pJIR750-FNR). 
We also observed that in the solvent production stage of 
ATCC824(pJIR750-FNR) at 48 hr, levels of acetone 
decreased and butyrate increased as compared to wild type 
vector control cells ATCC824(pJIR750). 
The effect on the ratio of butyrate to acetate was consid-
erable in M5 (Table 3). After 6 hr, the typical butyrate: 
acetate ratio of -1.14 was observed in control cultures of 
host M5 and M5(pJIR750) but in the strain M5(pJIR750-
FNR) expressing the ferredoxin NAD(P) reductase the ratio 
was -2.8, and after 24 hr culture the ratios were 1.85 in the 
MS cultures and 3.7 in the MS FNR+ cultures (Table 3). 
vate to produce acetyl-CoA, CO2 and reduced ferredoxin. 
The reduced ferredoxin plays a key role as an electron 
carrier and is able, under appropriate conditions, to transfer 
electron to the iron hydrogenase for H2 production. FIG. 1 40 
shows the major genes whose encoded proteins catalyze that 
reaction are shown in the pathway diagram. In some cases 
there are more than one enzyme that acts in a particular 
reaction, however the major one or ones are indicated in the 
diagram. 
To capture the lost redox via H2 production, we used 
ferredoxin-NAD(P)+ reductase (FNR) (EC 1.18.1.3, 
1.18.1.2) from the green sulphur bacterium Chlorobium 
tepidum TLS which is capable of efficiently catalyzing 
reduction of both NADP+ and NAD+, NAD+ being the 50 
more favorable, in the presence of reduced ferredoxin 
(Fdred). 
45 These results indicate the added enzyme can divert redox to 
NADH and generate a more reduced pattern of metabolites, 
such as butyrate and butanol. 
FNR 
Fd,-d + NAD(P/ + H+ ----- Felox + NAD(P)H 
where Fdred=reduced ferredoxin and Fd0 x =oxidized ferre-
doxin 
The 360 amino acid FNR protein encoding gene of 
Chlorobium tepidum was synthesized with a ribosome bind-
ing site (FIG. 2A-C) for the heterologous overexpression in 
Clostridium acetobutylicum strains ATCC824 and a degen-
erate strain (pSOLl -) M5 that camiot make acetone and 
butanol and buk- mutant with butyrate kinase knockout. 
Heterologous expression of synthesized FNR in Clostridia 
catalyzes the transfer of electrons while recycling ferredoxin 
In the buk- mutant strain expressing pJIR750 or pJIR750-
FNR, the levels of acetone, ethanol, acetate and butyrate 
were significantly different. In cultures ofbuk- fnr+ at 48 hr, 
the levels of acetone, acetate, butyrate and ethanol dropped 
to about 33%, 50%, 50% and 11 %, respectively. The buk-
(pJIR750-FNR) strain showed about 6% increase in butanol 
concentration at 48 hr as compared to buk- (pJIR750) vector 
55 alone strain. These changes were more significant in terms 
of butanol:acetone, total solvent/acid ratios and percent 
butanol of total solvents on gram basis. 
The butanol:acetone ratio for buk- (pJIR750) were 1.5 
and 2 as compared to 2.2 and 3.2 for buk- (pJIR750-FNR) 
60 at 24 and 48 hr, respectively. The solvent:acid ratio for buk-
(pJIR750) were 8.4 and 7.8 as compared to 11.7 and 13.9 for 
buk- (pJIR750-FNR) at 24 and 48 hr, respectively. The 
percent butanol of total solvents on gram basis for buk-
(pJIR 7 50) was 56 and 60 as compared to 63 and 68 for buk-
65 (pJIR750-FNR) at 24 and 48 hr, respectively. 
In summary, the advantages and features of using an 
overexpressed ferredoxin-NAD(P) oxidoreductase include: 
US 9,650,654 B2 
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1. Capturing of redox which is otherwise used in the 
production of hydrogen and thereby increased availability of 
NADH. 
2. Increased NADH levels in vivo results in formation of 
NADH dependent metabolites such as longer chain organic 
acid butyrate over acetate and butanol over acetone. 
3. Enhanced yield of butyrate. 
Ferredoxin--NADP(+) 
reductase 
ferredoxin--NADP 
5 reductase 
6 
-continued 
Anabaena cylindrica 
Nostoc sp. PCC 7120 
AFZ57822 
(GenBank) 
WP 010998260.1 
EC 1.18.1.3 - ferredoxin-NAD+ reductase 
Synonym Uniprot Species. 
10 Rnf 
The experiments herein show that the proportion of 
butanol and butyarate is increased in the presence of the 
FNR gene encoded by C. tepidium. There are also FNR 
genes from plants and cyanobacteria and Plasmonium fal-
ciparum ferredoxin-NADP+ reductase that could be used in 
the invention. Most of those show a high preference for 
15 NADPH. Additionally, quite a bit of work has been done on 
the Anabaena enzyme, and it is also a useful enzymes for use 
hereunder. 
D3POM6 
Ferredoxin--NAD(P)(+) 
reductase fdr (EC 1.18.1.2) 
(EC 1.18.1.3) (Carbazole 
1,9a-dioxygenase, 
ferredoxin reductase 
component) (CARDO) 
Ferredoxin--NAD(+) 
reductase (EC 1.18.1.3) 
Ferredoxin--NAD(+) 
D8GR70 
D3POM6 
D5IGG6 
F4CQP8 
Clostridium ijungdahlii 
Halorhabdus tiamatea 
SARL4B 
Sphingomonas sp. 
Pseudonocardia 
dioxanivorans 
One way to find other enzymes that can be used in the 
invention is by BLAST search of amino acid homologs: 
UniProt Species % AA identity 
Q8KCB2 Chlorobium tepidum 100.0% 
B3QPZ8 Chlorobaculurn parvum 90.8% 
A1BHP4 Chlorobium phaeobacteroides 76.6% 
B4SFQ3 Pelodictyon phaeoclathratiforme 76.6% 
QOYS49 Chlorobium ferrooxidans 75.7% 
Q3AS18 Chlorobium chlorochromatii 75.5% 
B3EEFO Chlorobium limicola 74.3% 
A4SFT9 Prosthecochloris vibrioformis 74.9% 
Q3B2Q8 Pelodictyon luteolum 73.5% 
B4S9F8 Prosthecochloris aestuari 71.6% 
Other FNR enzymes that might be used herein include 
those listed below, but typically several hundred are pro-
vided at e.g., UniProt or Brenda and other databases by 
protein name, gene name, by homology or by EC number. 
EC 1.18.1.2 - ferredoxin-NADP+ reductase 
Synonym 
ABO_Ol45 
ferredoxin-NADP+ 
oxidoreductase 
ferredoxin-NADP+ 
oxidoreductase 
FNRl 
ferredoxin:NADP+ 
reductase 
ferredoxin-NADP+ 
reductase 
PETH 
PETH 
FprA 
ferredoxin 
(flavodoxin)-
NADP(H) reductase 
FNR 
ferredoxin NADP+ 
oxidoreductase 
PETH 
ST2133 
FNR 
FNR 
FNR 
ferredoxin--NADP( +) 
reductase 
Species 
Alcanivorax borkumensis 
Arabidopsis thaliana 
Bacillus subtilis 
UniProt Acc. No. 
QOVTC7 
Q8W493 
F4JZ46 
Q9FKW6 
005268 
Chlamydomonas reinhardtii A8J6Y8 
Cryptosporidium parvum Q5CVU8 
Escherichia coli 
Nostoc sp. ATCC 29151 
Pisum sativum 
Pseudomonas putida 
Rhodobacter capsulatus 
Synechococcus elongatus 
Triticum aestivum 
Synechocystis sp. 
Sulfolobus tokodaii 
Zea mays 
Xanthomonas axonopodis 
Chlamydomonas reinhardtii 
Anabaena variabilis 
P28861 
P21890 
P10933 
T2HBT5 
Q9L6V3 
Q93RE3 
Q8RVZ8 
Q8RVZ9 
Q55318 
Q96YN9 
Q9SLP6 
Q8PMHO 
A8J6Y8 
CAA37973 
(GenBank) 
WP _011317640.1 
(GenBank) 
20 reductase GenePsed_1526 
Ferredoxin--NAD+ reductase 
protein (EC 1.18.1.3) (Ni/Fe 
hydrogenase, gamma 
subunit) 
Ferredoxin--NAD(+) 
25 reductase (EC 1.18.1.3) 
Ferredoxin--NAD(P)(+) 
reductase CarAd (EC 
1.18.1.2) (EC 1.18.1.3) 
(Carbazole 1,9a-
dioxygenase, ferredoxin 
30 reductase component) 
(CARDO) 
F4CU45 
F7PL38 
P24134 
Q8GI14 
Pseudonocardia 
dioxanivorans 
Halorhabdus tiamatea 
SARL4B 
Streptomyces griseus 
Pseudomonas 
resinovorans 
Each oflnitial cloning experiments sometimes proceed in 
E. coli for convenience since most of the required genes are 
35 
already available in plasmids suitable for expression in E. 
coli, but the addition of genes to bacteria is of nearly 
universal applicability, so it will be possible to use a wide 
variety of organisms with the selection of suitable vectors 
40 for same. Furthermore, a number of databases include vector 
information and/or a repository of vectors. See e.g., Addge-
ne.org which provides both a repository and a searchable 
database allowing vectors to be easily located and obtained 
from colleagues. See also Plasmid Information Database 
45 (PlasmID) and DNASU having over 191,000 plasmids. A 
collection of cloning vectors of E. coli is also kept at the 
National Institute of Genetics as a resource for the biological 
research community. Furthermore, vectors (including par-
ticular ORFS therein) are usually available from colleagues. 
50 The enzymes can be added to the genome or on expres-
sion vectors, as desired. Preferably, multiple enzymes are 
expressed in one vector or multiple enzymes can be com-
bined into one operon by adding the needed signals between 
coding regions. Further improvements can be had by over-
55 expressing one or more, or even all of the enzymes, e.g., by 
adding extra copies to the cell via plasmid or other vector. 
Initial experiments will employ expression plasmids hosting 
3 or more ORFs for convenience, but it may be preferred to 
insert operons or individual genes into the genome for 
60 stability reasons. 
Still further improvements in yield can be had be remov-
ing competing pathways, such as those pathways for making 
e.g., acetate, and it is already well known in the art how to 
reduce or knockout these pathways. Our own lab has several 
65 patent applications addressing such improvements, and such 
hosts may also make suitable starting materials since they 
are already available. 
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Generally speaking, we have referenced protein names 
herein and included EC numbers for accurate identification, 
but it is understood that a change in protein activity can of 
course be effected by changing the gene. This provides 
clarity since the gene nomenclature can be widely divergent 5 
in bacteria, but the proteins are defined by their activities and 
EC numbers. 
8 
The terms "comprise", "have", "include" and "contain" 
(and their variants) are open-ended linking verbs and allow 
the addition of other elements when used in a claim. 
Once an exemplary protein is obtained, e.g., in E. coli, 
which is completely sequenced and which is the workhorse 
of genetic engineering and bioproduction, many additional 
examples proteins of similar activity can be identified by 
BLAST search or database search. Further, every protein 
record is linked to a gene record, making it easy to design 
overexpression vectors. Many of the needed enzymes are 
already available in vectors, and can often be obtained from 
cell depositories or from the researchers who cloned them. 
But, if necessary, new clones can be prepared based on 
available sequence information using RT-PCR techniques. 
Thus, it should be easily possible to obtain all of the needed 20 
enzymes for overexpression, and in fact, we already have 
several clones, and are collecting the rest. 
As used herein, the expressions "cell", "cell line" and 
"cell culture" are used interchangeably and all such desig-
nations include progeny. Thus, the words "cells" and similar 
designations include the primary subject cell and cultures 
derived therefrom without regard for the number of trans-
fers. It is also understood that all progeny may not be 
10 precisely identical in DNA content, due to deliberate or 
inadvertent mutations that arise after genetic engineering is 
concluded. Mutant progeny that have the same function or 
biological activity as screened for in the originally trans-
15 formed cell are included. Where distinct designations are 
intended, it will be clear from the context. 
Understanding the inherent degeneracy of the genetic 
code allows one of ordinary skill in the art to design multiple 
nucleotides that encode the same amino acid sequence. 25 
NCBI™ provides codon usage databases for optimizing 
DNA sequences for protein expression in various species. 
Using such databases, a gene or cDNAmay be "optimized" 
for expression in E. coli or Clostridia or other bacterial 
species using the codon bias for the species in which the 30 
gene will be expressed. 
In calculating "% identity" the unaligned terminal por-
tions of the query sequence are not included in the calcu-
lation. The identity is calculated over the entire length of the 
reference sequence, thus short local alignments with a query 35 
sequence are not relevant (e.g., % identity=number of 
aligned residues in the query sequence/length of reference 
sequence). Alignments are performed using BLAST homol-
ogy alignment as described by Tatusova TA & Madden T L 
(1999) FEMS Microbial. Lett. 174:247-250. The default 40 
parameters were used, except the filters were turned OFF. As 
of Jan. 1, 2001 the default parameters were as follows: 
BLASTN or BLASTP as appropriate; Matrix=none for 
BLASTN, BLOSUM62 for BLASTP; G Cost to open gap 
default=5 for nucleotides, 1 1 for proteins; E Cost to extend 45 
gap [Integer] default=2 for nucleotides, 1 for proteins; q 
Penalty for nucleotide mismatch [Integer] default=-3; r 
reward for nucleotide match [Integer] default= 1; e expect 
value [Real] default=lO; W word size [Integer] default=! 1 
for nucleotides, 3 for proteins; y Dropoff (X) for blast 50 
extensions in bits ( default if zero) default=20 for blastn, 7 
for other programs; X dropoff value for gapped alignment 
(in bits) 30 for blastn, 15 for other programs; Z final X 
dropoff value for gapped alignment (in bits) 50 for blastn, 25 
for other programs. This program is available online at 55 
NCBI™ (ncbi.nlm.nih.gov/BLAST/). 
The terms "operably associated" or "operably linked," as 
used herein, refer to functionally coupled nucleic acid 
sequences. 
As used herein "recombinant" is relating to, derived from, 
or containing genetically "engineered" material. In other 
words, the genome was intentionally manipulated by the 
hand of man in some way. 
"Reduced activity" or "inactivation" is defined herein to 
be at least a 75% reduction in protein activity, as compared 
with an appropriate control species. Preferably, at least 80, 
85, 90, 95% reduction in activity is attained, and in the most 
preferred embodiment, the activity is eliminated (100%). 
Proteins can be inactivated with inhibitors, by mutation, or 
by suppression of expression or translation, and the like. A 
negative superscript, as in buk-, indicates reduced activity. 
"Overexpression" or "overexpressed" is defined herein to 
be at least 150% of protein activity as compared with an 
appropriate control species. If the gene/protein of is not 
available in the host species, any expression is overexpres-
sion. Overexpression can be achieved by mutating the 
protein to produce a more active form or a form that is 
resistant to inhibition, by removing inhibitors, or adding 
activators, and the like. Overexpression can also be achieved 
by removing repressors, adding multiple copies of the gene 
to the cell, or upregulating the endogenous gene, and the 
like. An overexpressed protein can be represented by the + 
symbol, e.g., FNR+. 
As used herein "100% anaerobic" refers to those condi-
tions of zero oxygen such that obligate anaerobes can grow. 
Anaerobic by contrast, may allow some very low degree of 
oxygen, such that anaerobes with some degree of oxygen 
tolerance can grow. It is now known that obligately anaero-
bic bacteria such as acetogenic bacteria are stable to periods 
of aerobiosis. See Wagner (1996). 
The terms "disruption" as used herein, refer to cell strains 
in which the native gene or promoter is mutated, deleted, 
interrupted, or down regulated in such a way as to decrease 
the activity of the protein at least 90% over the wild type 
un-disrupted protein. A gene or protein can be completely 
(100%) reduced by knockout or removal of the entire 
genomic DNA sequence. A knockout mutant can be repre-
As used herein the specification, "a" or "an" may mean 
one or more. As used herein in the claim(s), when used in 
conjunction with the word "comprising", the words "a" or 
"an" may mean one or more than one. As used herein 
"another" may mean at least a second or more. 
60 sented by the A symbol. 
The term "about" means the stated value plus or minus the 
margin of error of measurement or plus or minus 10% if no 
method of measurement is indicated. 
The use of the term "or" in the claims is used to mean 
"and/or" unless explicitly indicated to refer to alternatives 
only or if the alternatives are mutually exclusive. 
Use of a frame shift mutation, early stop codon, point 
mutations of critical residues, or deletions or insertions, and 
the like, can completely inactivate (100%) gene product by 
completely preventing transcription and/or translation of 
65 active protein. 
The following abbreviations, plasmids and strains are 
used herein: 
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ABBREVIATION 
FNR 
YTG 
CGM 
2xYTG 
PTB 
ctfA 
ctfB 
adc 
bla 
mlsR 
repL 
mlsR 
lacZ 
ori 
rep 
catP 
oriEC 
OD 
TH20 
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FULL NAME 
ferredoxin-NAD(P)' reductase (EC 1.18.1.3, 
1.18.1.2), sometimes called ferredoxin-NAD(P)+ 
oxidoreductase 
Yeast tryptone glucose mediwn, often used for 
clostridia 
Clostridial growtb medium; KH2P04 , 0. 75 g; 
K2HP04 , 0.75 g; MgS04 •H2 0, 0.4 g; 
MgS04 •H2 0, 0.01 g; FeS04 •7H2 0, 
0.01 g; NaCl, 1.0 g; asparagine, 2.0 g; yeast extract, 
5.0 g; (NH4 )2 S04 , 2.0 g; and 
carbohydrate, 5 g 
pH 5.8; 16 g Bacto tryptone, 10 g yeast extract, 
4 g NaCl, and 113 5 g glucose per L 
phosphotransbutyrylase promoter 
acetoacetyl-CoA:acetate/butyrate:CoA transferase 
subunit A 
acetoacetyl-CoA:acetate/butyrate:CoA transferase 
subunit B 
acetoacetate decarboxylase 
beta-lactarnase for arnpicillin resistance; repL, 
replication protein 
macrolide-lincosarnide-streptograrnin B resistance 
protein 
replication protein 
macrolide-lincosarnide-streptograrnin B resistance 
protein 
beta-galactosidase alpha-peptide; 
C. perfringens pIP404 replication origin; 
replication enzyme 
chlorarnphenicol acetyltransferase 
replication region 
Optical density 
Thiarnphenicol 20 µg/ml 
DESCRIPTION OF DRAWINGS 
FIG. 1. Metabolic pathways in C. acetobutylicum. Ferre-
doxin NAD(P) reductase (FNR) catalyzed reaction of uti-
lizing redox while reducing NAD(P) to NAD(P)H is shown 
10 
tein; mlsR, macrolide-lincosamide-streptogramin B 
resistance protein. Restriction enzyme sites: BamHI, KasI, 
NarI, Sall. 
FIG. 4. Plasmid Maps: Schematic diagram showing the 
5 construction ofpJIR750-FNR. The -1.4 Kb fragment con-
taining PTB promoter, ribosome binding site and codon 
optimized FNR (Ferredoxin-NADP reductase) of Chloro-
bium tepidum TLS was excised from pSOS94-FNR using 
restriction enzyme Sall, and ligated to Sall digested -6.6 Kb 
10 pJIR750. The newly constructed 7.9 Kb pJIR750-FNR 
expresses the FNR under constitutive PTB promoter. Abbre-
viations: PTB, phosphotransbutyrylase promoter; FNR, 
codon optimized ferredoxin-NADP reductase gene from C. 
15 tepidum; bla, beta-lactamase for ampicillin resistance; repL, 
replication protein; mlsR, macrolide-lincosamide-strepto-
gramin B resistance protein; lacZ, beta-galactosidase alpha-
peptide; ori, C. perfringens pIP404 replication origin; rep, 
replication enzyme; catP, chloramphenicol acetyltrans-
20 ferase; oriEC, replication region. Restriction enzyme sites: 
BamHI, KasI, NarI, Sall, EcoRI, Sacl, KpnI, XbaI, PstI, 
SphI, HindIII. 
FIG. 5. C. acetobutylicum pathways and pSOLl genes. 
Metabolic pathways in C. acetobutylicum and associated 
25 calculated in vivo fluxes. Selected enzymes are shown in 
bold and associated intracellular fluxes are shown in italics. 
Enzymes are abbreviated as follows: hydrogenase (HYDA); 
phosphotransacetylase (PTA); acetate kinase (AK); thiolase 
(THL); ~-hydroxybutyryl dehydrogenase (BHBD); croto-
30 nase (CRO); butyryl-CoA hydrogenase (BCD); CoA Trans-
ferase (CoAT); acetoacetate decarboxylase (AADC); 
butyrate kinase (BK); phosphotransbutyrylase (PTB); alco-
hol/aldehyde dehydrogenase (AAD). Note: AAD is believed 
to be the primary enzyme for butanol and ethanol formation 
35 but additional genes exist that code for alcohol forming 
enzymes (adhe2, bdhA, bdhB, CAC3292, CAP0059) The 
pathways whose genes reside on the pSOLl megaplasmid 
and are absent in M5 are shown as dotted lines. The boxed 
pathway shows the ATP generation and NADH production 
in the box. pfor: pyruvate ferredoxin oxidoreductase; ack: 
acetate kinase; pta: phosphate acetyltransferase; adhE: alde-
hyde alcohol dehydrogenase; bdhAB: butanol dehydroge-
nase; edh: ethanol dehydrogenase; th!: acetoacetyl-CoA 
thiolase; hbd: 3-hydroxybutyryl-CoA dehydrogenase; adc: 
acetoacetate decarboxylase; ctfAB: butyrate-acetoacetate 
CoA-transferase; crt: 3-hydroxybutyryl-CoA dehydratase; 
bed: butyryl-CoA dehydrogenase; ptb: phosphotransbutyry- 45 
lase; buk: butyrate kinase. 
40 occurring during metabolism. 
DETAILED DESCRIPTION 
The disclosure relates to bacteria for making C4+ organic 
acids, alcohols or derivatives thereof, as well as to methods 
of making C4+ organic acids, alcohols or derivatives there-
from by culturing the engineered bacteria described herein 
with a source of carbon, forming C4+ organic acids, alcohols 
or derivatives, harvesting said C4+ products. The products 
can be used as is, or converted to other desirable compounds 
such as alkanes, alkenes, alcohols, esters, acids, amides, and 
the like. 
FIG. 2A SEQ ID NO. 1 Amino acid sequence of native 
Ferredoxin-NAD(P) reductase (FNR) of Chlorobium tepi-
dum TLS (GenBankAccession Q8KCB2), and FIG. 28 SEQ 
ID NO. 2. Optimized nucleotide sequence of FNR for 50 
expression in Clostridium acetobutylicum ATCC 824. FIG. 
2C SEQ ID NO. 3. Synthetic ribosome binding site. 
FIG. 3. Plasmid Maps: Schematic diagram showing the 
construction of pSOS94-FNR. The 1.1 Kb FNR (Ferre-
doxin-NAD(P) reductase) of Chlorobium tepidum TLS was 
codon optimized for expression in Clostridium acetobutyli-
cum, synthesized with ribosome binding site (rbs), and 
cloned in pSOS94 using BamHI and KasI sites. The newly 
constructed-6.1 Kb pSOS94-FNR expresses the FNR under 
constitutive PTB promoter. Abbreviations: PTB, phospho-
transbutyrylase promoter; ctfA, acetoacetyl-CoA:acetate/ 
butyrate:CoA transferase subunit A; ctfB, acetoacetyl-CoA: 
acetate/butyrate:CoA transferase subunit B; adc, 
acetoacetate decarboxylase; FNR, codon optimized ferre- 65 
doxin-NADP reductase gene from C. tepidum; bla, beta-
lactamase for ampicillin resistance; repL, replication pro-
55 
60 
Preferred compounds made herein include the saturated 
C4-C8 acids (or esters thereof): 
Butyric acid Butanoic acid CHs(CH2hCOOH C4:0 
Valerie acid Pentanoic acid CH3 (CH2hCOOH C5:0 
Caproic acid Hexanoic acid CH3 (CH2 ) 4COOH C6:0 
Enantbic acid Heptanoic acid CH3 (CH2)sCOOH C7:0 
Caprylic acid Octanoic acid CHs(CH2 ) 6COOH C8:0 
Pelargonic acid Nonanoic acid CH3 (CH2hCOOH C9:0 
Other preferred products include the alcohols, butanol, 
pentanol, hexanol, heptanol and octanol. 
Preferably, the above bacteria also have reduced fermen-
tation pathways leading to competing products, such as 
acetate, lactate, ethanol and/or formate. Many such mutants 
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are already available in the art and can be used as host cells, 
or the vectors can be used to introduce same. 
Acetogens are a useful starting host, as they may contain 
one or more of the required enzymes (e.g., certain bacteria 
contain an enzyme for reaction 6), and be suitable for 5 
making C4-8 or C4-10 products. Most acetogens use the 
"Wood-Ljungdahl" pathway. The Wood-Ljungdahl pathway 
is a set of biochemical reactions used by some bacteria and 
archaea. It is also known as the reductive acetyl-CoA 
pathway, and enables certain organisms to use hydrogen as 10 
an electron donor and carbon dioxide as an electron acceptor 
as well as a building block for biosynthesis. In this pathway 
carbon dioxide is reduced to carbon monoxide, which is then 
converted to acetyl coenzyme A. Two enzymes participate, 
CO Dehydrogenase and acetyl-CoA synthase. The former 15 
catalyzes the reduction of the CO2 and the latter combines 
the resulting CO with a methyl group to give acetyl-CoA. 
Unlike the Reverse Krebs cycle and the Calvin cycle, this 
process is not cyclic. 
Many acetogens are thought to be strict anaerobes, thus it 20 
may be preferred to perform some of the needed engineering 
in a more easily grown bacteria, such as E. coli, or other 
commonly engineering microbe. However, acetogens are 
also present in aerated soils and colonize habitats with 
fluctuating redox conditions ( e.g., the rhizosphere of sea 25 
grass), suggesting that less strict isolates are obtainable, as 
confirmed by Mullin's work. The use of anaerobes that are 
less strict may be preferred as maintaining 100% anaerobic 
conditions is difficult and costly. 
Other acetogens include Clostridium autoethanogenum, 30 
Eurobacterium limosum, Clostridium carboxidivorans P7, 
Peptostreptococcus products, and Butyribacterium methylo-
trophicum, Clostridium ljungdahlii and Acetobacterium 
woodii. 
Still other bacteria that could be useful hosts include 35 
Clostridium, Butyrobacterium, Moorella thermoacetica, 
Sporomusa, Thermacetogenium phaeum, Clostridium ther-
mocellum, Acetogenium kivui, Acetobacterium woodii, 
Butyribacterium methylotrophicum, Clostridium ljungdah-
lii, Clostridium thermoautotrophicum, Clostridium tyrobu- 40 
tyricum, or Eubacterium limosum, or any other organism 
that uses ferredoxin as a major means of electron transfer 
factor. 
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A bacteria as described herein, further compnsmg a 
mutation such that said bacteria camiot make acetone, 
lactate, formate or combinations thereof 
A bacteria as described herein, wherein said bacteria is an 
acetogenic bacteria. 
A bacteria as described herein, wherein said bacteria is a 
Clostridium, Clostridium acetobutylicum, Clostridium 
acetobutylicum MS, Clostridium thermocellum, 
Clostridium ljungdahlii, Clostridium thermoauto-
trophicum, or Clostridium tyrobutyricum. 
A bacteria as described herein, wherein said bacteria is a 
Butyrobacterium, Moorella thermoacetica, Sporomusa, 
Thermacetogenium phaeum, Acetogenium kivui, Aceto-
bacterium woodii, or Eubacterium. 
A bacteria as described herein, The bacteria of claim 1, 
wherein said bacteria is Clostridium acetobutylicum 
MS. 
A method for the bioproduction of a C4+ compound, said 
method comprising: 
anaerobically growing a bacteria as described herein in 
a culture medium comprising a carbon source; 
conversion of said carbon source to a C4+ compound; 
and 
purification of said C4+ compound. 
A method as herein described, wherein said C4+ com-
pound is butyrate, butanol, valeric acid, pentanol, 
hexanoate, hexanol, heptanoate, heptanol, octanoate, 
octanol, or a derivative thereof, and is preferably, 
butyrate, butanol or derivatives thereof 
A method as herein described, wherein said growing step 
is anaerobic. 
A method as herein described wherein said growing step 
is 100% anaerobic. 
A method as herein described, wherein said growing step 
is <100% anaerobic, e.g., the bacteria is not a strict 
anaerobe. Such bacteria can be selected for some 
degree of oxygen tolerance before or after the genetic 
engineering step. 
Materials and Methods 
Experiments were performed in anaerobic glove box 
containing 85% N2 , 10% H2 and 5% CO2 atmosphere. 
Glycerol stocks of C. acetobutylicum ATCC 824 and its In more detail, the invention includes one or more of the 
following embodiments in any combination thereof: 
A genetically engineered bacteria, comprising an overex-
pressed ferredoxin-NAD(P)+ reductase (FNR) capable 
of catalyzing reduction of either NADP+ or NAD+ or 
both, said bacteria able to anaerobically produce more 
C4-8 organic acids or alcohols than a similar bacteria 
lacking said overexpressed FNR. 
45 mutant strain M5 (Clark 1989) harboring pSOS94-FNR 
(FIG. 3) or pJIR750-FNR (FIG. 4) were streaked on 2xYTG 
and incubated at 37° C. for 2-5 days. Preculture was 
prepared by inoculating a single colony from 2xYTG plate 
in 10 mL of CGM + containing 25 mg/L thiamphenicol or 40 
A genetically engineered acetogenic bacteria, comprising 
50 mg/L erythromycin in 15 mL falcon tube and incubated at 
37° C. for 14-16 h. 200 µL of preculture was used as 
inoculum for fermentation experiments performed in 15 mL 
tubes with loose cap containing 10 mL CGM+ with 50 g/L an overexpressed heterologous ferredoxin-NAD(P)+ 
reductase (FNR) capable of efficiently catalyzing 
reduction of both NADP+ and NAD+, said bacteria 55 
able to anaerobically produce more C4-C8 organic 
acids or alcohols than a similar bacteria lacking said 
overexpressed heterologous FNR. 
glucose at 37° C. without shaking. 
Samples were collected at various time points to measure 
OD600 and metabolites. 1 mL sample was centrifuged at 
12,000 rpm for 5 min at room temperature to remove cell 
debris and clear supernatant was acidified with 20 µL 50% 
H2 S04 . Metabolites such as ethanol, acetone, acetic acid, A genetically engineered Clostridial bacteria, comprising 
an overexpressed heterologous ferredoxin-NAD(P)+ 
reductase (FNR) capable of efficiently catalyzing 
reduction of both NADP+ and NAD+, said bacteria 
able to anaerobically produce more C4-C8 organic 
acids or alcohols than a similar bacteria lacking said 
overexpressed heterologous FNR. 
A bacteria as described herein, wherein said FNR is a 
heterologous FNR. 
60 butanol and butyric acid were measured by gas chromatog-
raphy equipped with FID detector and PoraPak™ QS 80/100 
glass colunm. 
In the Tables below, ATCC824 is wild type Clostridium 
acetobutylicum. MS is a pSOLl - mutant strain of the same 
65 bacterium. This mutant is used to show that the redistribu-
tion of redox from reduced Fd can generate longer chain 
acids in the metabolite profile of an acidogenic culture, and 
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producing mutant both carry the MLS drug resistance 
marker for erythromycin. Thus, the use of a shuttle vector 
with a different selectable marker was needed. 
A single colony from transformation plate (2xYTG agar 
would be similar to the acidigenic metabolites produced by 
Clostridium tyrobutyricum or clostridium butyricum, as an 
example of the effect on a non-solvent producing 
clostridium species. The A and B refer to different isolates 
from the same transformation. 
pJIR750 is a Clostridium perfringens-Escherichia coli 
shuttle vector derived from pJIR418 (ATCC 77387) permit-
ting expression of antibiotic resistance ( chloramphenicol 
resistance (catP)) in both hosts. pJIR750-FNR contains a 
codon optimized gene for FNR (SEQ ID NO. 2). 
5 plate with Thiamphenicol 20 µg/ml) inoculated in 10 mL 
CGM+ medium containing Th20----18 hat 37° C. (CGM+ is 
a modified CGM recipe with 50 g/L glucose) 100 µl of 
preculture inoculated in 10 mL CGM+ in 15 ml tube+ 
Th20-37° C. for 72 hours. 1 ml sample collected at 6 h, 24 
10 
h, 48 h and 72 h----centrifuged, acidified with 20 µL 50% 
H2 S04 and ran on GC for metabolites and the results shown 
in Tables 4-7. 
TABLE 1 The experimental is as described in the previous 
examples. 
Table 4 shows the addition of the plasmid with the FNR+ butyrate/acetate ratio of wild type C. acetobutylicum witb 
or witbout FNR from Chlorobium tepidium 15 does not drastically effect the growth or OD value. The 
Butyrate:Acetate ratio 
Strain 6h 24 h 48 h 72 h 
ATCC824(pJIR750)_A 0.72 0.40 0.51 0.47 
ATCC824(pJIR750)_B 1.11 0.50 0.46 0.37 
ATCC824(pJIR750-FNR)_A 1.53 0.65 0.86 1.13 
ATCC824(pJIR750-FNR)_B 1.65 0.67 1.04 1.20 
TABLE 2 
butanol/acetone ratio of wildtype C. acetobutylicum witb 
or witbout FNR from Chlorobium tepidium 
Strain 6h 
ATCC824(pJIR750)_A 14.78 
ATCC824(pJIR750)_B 18.16 
ATCC824(pJIR750-FNR)_A 29.52 
ATCC824(pJIR750-FNR)_B 23.41 
Butanol:Acetone ratio 
24 h 48 h 
1.55 1.50 
1.37 1.46 
2.23 2.36 
2.28 2.80 
72 h 
1.55 
1.57 
2.70 
3.18 
TABLE 3 
butyrate/acetate ratio of pSOLl - mutant C. acetobutylicum 
with or witbout FNR from Chlorobium tepidium 
Butyrate:Acetate ratio 
Strain 6h 24 h 48 h 72 h 
MS _A 1.21 2.15 2.21 2.03 
MS B 0.93 1.61 1.85 1.71 
-
M5(pJIR750)_A 1.17 1.78 1.77 1.71 
M5(pJIR750)_B 1.23 1.83 1.88 1.73 
M5 (pJIR7 50-FNR)_A 4.61 3.97 4.35 3.81 
M5 (pJIR7 50-FNR)_B 2.34 3.45 3.65 3.15 
20 
25 
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The following experiment was done in a mutant of 
Clostridium acetobutylicum-PJC4BK-that is disrupted in 
buk, the gene encoding the major butyrate kinase, and called 
BUK or buk- herein. This strain has higher butanol forma- 55 
tion than the parent ATCC824 because it is limited for the 
pathway from butyryl-CoA to butyrate as described in Green 
(1996). It was used as a host for the same plasmids described 
above in order to show the effect in a higher solvent forming 
derivative of C. acetobutylicum that already produces a 60 
higher level of butanol than the wild type parent. 
pJIR750-FNR has a Sall fragment ofpSOS94-FNR sub-
cloned into pJIR750. pSOS94-FNR contains codon opti-
mized Ferredoxin NAD(P) reductase of Chlorobium 
tepidium (DNA2.0 construct). pSOS94 is another shuttle 65 
vector for Clostridia, but the FNR was moved because the 
pSOS vector and the chromosome of the high solvent 
control Buk-JIR750 is with a plasmid alone with no FNR 
gene in it. The test strain has FNR encoded by the same 
vector. A and B are two different isolates from the same 
transformation. 
TABLE 4 
OD oftbe cultures Bulc JIR750 and Buk- JIR750-FNR+ 
Strain Short name 6 hr 24 hr 48 hr 
Buk- JIR750 - A Control-! 0.7 12.54 11 
Buk- JIR750 - B Control-2 0.6 12.16 12.4 
Buk- JIR750-FNR+ - A FNR-1 0.5 10.64 11.6 
Buk- JIR750-FNR+ - B FNR-2 0.5 9.12 11 
The metabolite analysis of the fermentation products of 
the cultures is seen in Table 5, where butanol production is 
considerably improved. 
TABLE 5 
Metabolite levels in BUK Clostridium witb or witbout FNR 
Buk host plus vector alone - control-! and control 2 
Buk(pJIR750-FNR) - FNR-1 & FNR-2 
mM of metabolite 
Control-!_ 48 h 
Etbanol 39.938 
Acetone 47.160 
Acetate 10.382 
Butanol 95.580 
Butyrate 12.730 
Control-2 _48 h 
Etbanol 39.706 
Acetone 49.680 
Acetate 9.730 
Butanol 97.840 
Butyrate 14.350 
FNR-1 _48 h 
Etbanol 36.705 
Acetone 30.460 
Acetate 6.080 
Butanol 102.290 
Butyrate 6.220 
FNR-2 _48 h 
etbanol 33.966 
acetone 33.550 
acetate 5.640 
butanol 104.420 
butyrate 6.590 
Looking at important ratios for high butanol production 
processes, the effect of the added enzyme is significant and 
positive, as seen in Tables 6-8. 
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TABLE 6 
Solvent/acid ratio metabolite levels in BUK Clostridium 
witb or witbout FNR. The solvents are a total of butanol plus 
acetone plus ethanol the acids are acetate and butyrate 
Control-! 
Control-2 
FNR-1 
FNR-2 
24 h 
8.533 
8.329 
12.150 
11.362 
TABLE 7 
48 h 
7.904 
7.775 
13.777 
14.059 
% Butanol of total solvents (g/L basis) in BUK Clostridium 
witb or witbout FNR 
Strains 24 h 48 h 72 h 
Control-! 56.708 60.741 65.013 
Control-2 56.82 60.6 64.136 
FNR-1 63.687 68.664 72.274 
FNR-2 63.494 68.778 73.057 
TABLE 8 
Acetone and Butanol witb FNR from C. tepidium 
in a BUK background 
Butanol Butanol/ Butanol/ 
Acetone (mM) (mM) acetone acetone 
Strain 72 hrs 72 hrs 48 hrs 72 hrs 
buk pJIR750 41.8 102 2.0 2.44 
buk pJIR750-FNR 24.7 106 3.23 4.32 
16 
reduce the crotonyl-CoA to butyryl-CoA and has been used 
in E. coli to make butanol. However, our results show that 
it will not function as intended herein. 
A different TER was tested and also found to be non-
5 functional, suggesting that the above result is generally 
applicable. The gene coding for the T. denticola enzyme 
(Acc. No. NP_971211.1) was synthesized, expression opti-
mized by DNA2.0, cloned into the vector pJIR750 and 
transformed into C. acetobutylicum MS (a non-solvent pro-
10 ducing strain) so acetate vs butyrate can be examined. Table 
11 shows a reduction of butyrate, rather than an improve-
ment. 
15 
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TABLE 11 
Acetate and Butyrate witb TER from Treponema denticola 
in pSOL - background 
Acetate MM Butyrate (mM) butyrate/acetate ratio 
STRAIN 24 HR 24 hr 24 hr 
M5 pJIR750 24.9 44.7 1.8 
OD - 5.5 
M5 pJIR750-TER 22.4 33.5 1.5 
OD - 5.9 
Acetone 
(mM) Butanol (mM) butanol/acetone ratio 
72 hrs 72 hrs 72 hr 
M5 pJIR750 47.8 74.7 1.56 
M5 pJIR750-TER 25.8 49.4 1.91 
The butanol mass proportion is shown in Table 9, and 35 
butanol/solvent in Table 10. 
The TER experiments were another way of doing the 
NADH utilization as this enzyme reduced the crotonyl-CoA 
to butyryl-CoA with just NADH rather than the Clostridial 
enzyme that uses NADH and oxidized Fd and gives butyryl-
CoA and reduced Fd and NAD in a more complex bifur-
cating reaction. It was synthesized and expressed in the same 
TABLE 9 
Butanol mass proportion witb FNR from C. tepidium 
in a BUK background 
Butanol as 
% of total Butanol as Butanol as 
metabolites % of total % of total 
(g/L) metabolites (g/L) metabolites (g/L) 
Strain 24 hrs 48 hrs 72 hrs 
buk pJIR750 51.6 54.3 58.3 
buk pJIR750-FNR 60.8 65.8 69.9 
TABLE 10 
Butanol mass solvent proportion witb FNR from C. tepidium 
in a BUK background 
Butanol as Butanol as Butanol as 
% of total % of total % of total 
solvents (g/L) solvents (g/L) solvents (g/L) 
Strain 24 hrs 48 hrs 72 hrs 
buk pJIR750 59.3 62.6 66.9 
buk pJIR750-FNR 66.8 71.4 75.5 
These experiments show that the proportion of butanol 
and butyrate is increased in the presence of the FNR gene 
encoded by C. tepidium. 
way as the FNR enzyme, but it had a lowering effect on the 
butyrate and butanol in the way it was expressed and tested. 
These negative results suggest that the minimum require-
40 ment for functionality hereunder is addition of extra ferre-
doxin NAD(P)H reductase activity. We did not test TER in 
the presence of FNR to see if the coupled system had a 
positive effect. 
45 
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<160> NUMBER OF SEQ ID NOS, 3 
<210> SEQ ID NO 1 
<211> LENGTH, 360 
<212> TYPE, PRT 
SEQUENCE LISTING 
<213> ORGANISM, Chlorobium tepidum 
<400> SEQUENCE, 1 
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1-butanol synthesis in Escherichia coli. Appl Environ 
Microbial. 77(9):2905-15. 
Met Leu Asp Ile His Asn Pro Ala Thr Asp His His Asp Met Arg Asp 
1 5 10 15 
Leu Thr Ile Ile Gly Gly Gly Pro Thr Gly Ile Phe Ala Ala Phe Gln 
20 25 30 
Cys Gly Met Asn Asn Ile Ser Cys Arg Ile Ile Glu Ser Met Pro Gln 
35 40 45 
Leu Gly Gly Gln Leu Ala Ala Leu Tyr Pro Glu Lys His Ile Tyr Asp 
50 55 60 
Val Ala Gly Phe Pro Glu Val Pro Ala Ile Asp Leu Val Glu Ser Leu 
65 70 75 80 
Trp Ala Gln Ala Glu Arg Tyr Asn Pro Asp Val Val Leu Asn Glu Thr 
85 90 95 
Val Thr Lys Tyr Thr Lys Leu Asp Asp Gly Thr Phe Glu Thr Arg Thr 
100 105 110 
Asn Thr Gly Asn Val Tyr Arg Ser Arg Ala Val Leu Ile Ala Ala Gly 
115 120 125 
Leu Gly Ala Phe Glu Pro Arg Lys Leu Pro Gln Leu Gly Asn Ile Asp 
130 135 140 
His Leu Thr Gly Ser Ser Val Tyr Tyr Ala Val Lys Ser Val Glu Asp 
145 150 155 160 
Phe Lys Gly Lys Arg Val Val Ile Val Gly Gly Gly Asp Ser Ala Leu 
165 170 175 
Asp Trp Thr Val Gly Leu Ile Lys Asn Ala Ala Ser Val Thr Leu Val 
180 185 190 
His Arg Gly His Glu Phe Gln Gly His Gly Lys Thr Ala His Glu Val 
195 200 205 
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-continued 
Glu Arg Ala Arg Ala Asn Gly Thr Ile Asp Val Tyr Leu Glu Thr Glu 
210 215 220 
Val Ala Ser Ile Glu Glu Ser Asn Gly Val Leu Thr Arg Val His Leu 
225 230 235 240 
Arg Ser Ser Asp Gly Ser Lys Trp Thr Val Glu Ala Asp Arg Leu Leu 
245 250 255 
Ile Leu Ile Gly Phe Lys Ser Asn Leu Gly Pro Leu Ala Arg Trp Asp 
260 265 270 
Leu Glu Leu Tyr Glu Asn Ala Leu Val Val Asp Ser His Met Lys Thr 
275 280 285 
Ser Val Asp Gly Leu Tyr Ala Ala Gly Asp Ile Ala Tyr Tyr Pro Gly 
290 295 300 
Lys Leu Lys Ile Ile Gln Thr Gly Leu Ser Glu Ala Thr Met Ala Val 
305 310 315 320 
Arg His Ser Leu Ser Tyr Ile Lys Pro Gly Glu Lys Ile Arg Asn Val 
325 330 335 
Phe Ser Ser Val Lys Met Ala Lys Glu Lys Lys Ala Ala Glu Ala Gly 
340 345 350 
Asn Ala Thr Glu Asn Lys Ala Glu 
355 360 
<210> SEQ ID NO 2 
<211> LENGTH, 1080 
<212> TYPE, DNA 
<213> ORGANISM, Clostridium acetobutylicum 
<400> SEQUENCE, 2 
atgttagata tccataatcc 
ggcggtggtc cgaccgggat 
agaatcattg aatctatgcc 
catatctatg acgttgcagg 
tgggcacaag cggaaagata 
accaaattag acgatgggac 
agagctgtac ttattgcagc 
ggcaatatag atcatctaac 
ttcaaaggta aaagagttgt 
ggacttatca aaaatgctgc 
catggtaaaa ccgcccatga 
ttggaaacag aggtagcaag 
agatcaagtg acggttcaaa 
tttaagtcaa acttaggtcc 
gttgttgatt ctcacatgaa 
tattacccgg ggaaattgaa 
aggcattccc ttagttatat 
aagatggcga aagaaaagaa 
<210> SEQ ID NO 3 
<211> LENGTH, 14 
<212> TYPE, DNA 
agcaaccgac caccatgata 
atttgctgcc tttcaatgtg 
tcaattgggt ggtcaacttg 
atttcccgaa gttccagcta 
taacccagat gtcgtcctta 
gtttgagact agaaccaata 
gggattagga gcatttgaac 
cggtagttct gtatactatg 
tatagtcggt ggtggagaca 
atcagtaaca ttagtgcaca 
agtggaaaga gcaagagcta 
cattgaagag tctaatggag 
gtggactgtt gaagcggata 
tttagcaaga tgggatttag 
aacttccgtt gacggacttt 
aatcatacag actgggttat 
caaacctggt gagaaaatac 
agccgcagaa gctgggaatg 
<213> ORGANISM, Artificial Sequence 
tgagagattt 
gtatgaataa 
ctgcactata 
ttgatttggt 
atgaaacagt 
caggtaatgt 
cacgtaaact 
cggttaaaag 
gcgccttaga 
gaggacatga 
atggtactat 
tattaactag 
gacttcttat 
aactttatga 
atgctgcagg 
cagaagcgac 
gtaacgtgtt 
ctactgagaa 
gactattatc 
catatcatgc 
tccagaaaaa 
tgagtcatta 
aaccaagtat 
ttatcgatca 
tccccaatta 
cgttgaagat 
ctggaccgtc 
atttcaaggt 
tgatgtgtat 
agttcatctt 
tctaataggt 
aaatgcttta 
agacattgca 
tatggctgta 
cagttccgtc 
taaggctgag 
20 
60 
120 
180 
240 
300 
360 
420 
480 
540 
600 
660 
720 
780 
840 
900 
960 
1020 
1080 
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-continued 
<220> FEATURE, 
<223> OTHER INFORMATION, Ribosome binding site 
<400> SEQUENCE, 3 
aggaggtaaa acat 
The invention claimed is: 10 
1. A method for the bioproduction of a C4+ compound, 
said method comprising: a. anaerobically growing a bacteria 
in a culture medium comprising a carbon source; b. conver-
sion of said carbon source to a C4+ compound; and c. 
purification of said C4+ compound, 15 
said bacteria being a genetically engineered bacteria com-
prising an overexpressed ferredoxin-NAD(P)+ reduc-
tase (FNR) capable of catalyzing reduction of either 
NADP+ or NAD+ or both, said bacteria able to anaero- 20 
bically produce more C4-8 organic acids or alcohols 
than a similar bacteria lacking said overexpressed FNR. 
2. The method of claim 1, wherein said C4+ compound is 
butyrate, butanol, valeric acid, pentanol, hexanoate, hexa-
nol, heptanoate, heptanol, octanoate, octanol, or a derivative 
thereof. 25 
3. The method of claim 1, wherein said C4+ compound is 
butyrate. 
4. The method of claim 1, wherein said C4+ compound is 
butanol. 
5. The method of claim 1, wherein said growing step is 
anaerobic. 
6. The method of claim 1, wherein said growing step is 
100% anaerobic. 
30 
14 
7. The method of claim 1, wherein said growing step is 
<100% anaerobic. 
8. The method of claim 1, wherein said FNR is a heter-
ologous FNR. 
9. The method of claim 1, said bacteria further comprising 
a mutation such that said bacteria cannot make lactate. 
10. The method of claim 1, wherein said bacteria is an 
acetogenic bacteria. 
11. The method of claim 1, wherein said bacteria is a 
Clostridium, Clostridium acetobutylicum, Clostridium 
acetobutylicum MS, Clostridium thermocellum, Clostridium 
ljungdahlii, Clostridium thermoautotrophicum, or 
Clostridium tyrobutyricum. 
12. The method of claim 1, wherein said bacteria is a 
Butyrobacterium, Moorella thermoacetica, Sporomusa, 
Thermacetogenium phaeum, Acetogenium kivui, Acetobac-
terium woodii, or Eubacterium. 
13. The method of claim 10, said bacteria further com-
prising a mutation such that said bacteria cannot make 
acetone. 
14. The method of claim 10, said bacteria further com-
prising a mutation such that said bacteria cannot make 
lactate. 
* * * * * 
